These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18249125)

  • 1. Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.
    Kumar SK; Roy I; Anchoori RK; Fazli S; Maitra A; Beachy PA; Khan SR
    Bioorg Med Chem; 2008 Mar; 16(6):2764-8. PubMed ID: 18249125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
    Chandran SS; Nan A; Rosen DM; Ghandehari H; Denmeade SR
    Mol Cancer Ther; 2007 Nov; 6(11):2928-37. PubMed ID: 18025277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating paclitaxel bioavailability for targeting prostate cancer.
    Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
    Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
    Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
    Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopamine bioactivity by extraction method from Veratrum californicum.
    Turner MW; Cruz R; Mattos J; Baughman N; Elwell J; Fothergill J; Nielsen A; Brookhouse J; Bartlett A; Malek P; Pu X; King MD; McDougal OM
    Bioorg Med Chem; 2016 Aug; 24(16):3752-7. PubMed ID: 27338657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
    Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
    Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
    J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer.
    Mhaka A; Denmeade SR; Yao W; Isaacs JT; Khan SR
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2459-61. PubMed ID: 12161157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma.
    Balbous A; Renoux B; Cortes U; Milin S; Guilloteau K; Legigan T; Rivet P; Boissonnade O; Martin S; Tripiana C; Wager M; Bensadoun RJ; Papot S; Karayan-Tapon L
    Mol Cancer Ther; 2014 Sep; 13(9):2159-69. PubMed ID: 25053823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
    Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
    Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.
    Khan SR; Denmeade SR
    Prostate; 2000 Sep; 45(1):80-3. PubMed ID: 10960846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling.
    Fan Q; Gu D; He M; Liu H; Sheng T; Xie G; Li CX; Zhang X; Wainwright B; Garrossian A; Garrossian M; Gardner D; Xie J
    Chin J Cancer; 2011 Jul; 30(7):472-81. PubMed ID: 21718593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Hundred Faces of Cyclopamine.
    Iovine V; Mori M; Calcaterra A; Berardozzi S; Botta B
    Curr Pharm Des; 2016; 22(12):1658-81. PubMed ID: 26759083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway.
    Yuan YF; Zhu WX; Liu T; He JQ; Zhou Q; Zhou X; Zhang X; Yang J
    Int J Mol Med; 2020 Jul; 46(1):311-319. PubMed ID: 32319534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs.
    Chen JK
    Nat Prod Rep; 2016 May; 33(5):595-601. PubMed ID: 26787175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified.
    Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S
    J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
    Mimeault M; Johansson SL; Vankatraman G; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
    Mol Cancer Ther; 2007 Mar; 6(3):967-78. PubMed ID: 17363490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.
    Peluso MO; Campbell VT; Harari JA; Tibbitts TT; Proctor JL; Whitebread N; Conley JM; White KF; Kutok JL; Read MA; McGovern K; Faia KL
    PLoS One; 2014; 9(3):e90534. PubMed ID: 24608250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.